drugset / Trial / NCT06303752
Tissue Therapy of Transsphincteric Anal Fistula
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical study aims to evaluate the outcome of the treatment of complex perianal fistulas (PAF) by the combination of minimal surgical debridement with regenerative cellular therapeutics.
Timeline
- Start
- 2024-10-09
- Primary completion
- 2027-10-08
- Completion
- 2028-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADRC | Cell therapy | 5 ml | Other |
| Subject | ADRC | Cell therapy | 30 cells | Other |
| Subject | ADRC001 | Cell therapy | 5 ml | Other |
| Subject | ADRC001 | Cell therapy | 30 cells | Other |